SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-112194
Filing Date
2021-09-02
Accepted
2021-09-02 06:04:40
Documents
2
Group Members
FRESENIUS MEDICAL CARE AG & CO. KGAA

Document Format Files

Seq Description Document Type Size
1 SC 13D a21-25521_1sc13d.htm SC 13D 122528
2 EX-99.1 a21-25521_1ex99d1.htm EX-99.1 70652
  Complete submission text file 0001104659-21-112194.txt   195150
Mailing Address
Business Address TWO LEDGEMONT CENTER 95 HAYDEN AVE LEXINGTON MA 02420 6174029000
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ (Filed by) CIK: 0000042872 (see all company filings)

IRS No.: 133461988 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences

Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Subject) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91701 | Film No.: 211231647
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences